Streetbeat News

PGNT

Paragon Technologies Inc

Employees

Industry

Iron and Steel Forging

Open

9.95

Mkt cap

15M

Volume

High

9.95

P/E Ratio

-9.48

52-wk high

10.70

Low

9.95

Div yield

N/A

52-wk low

5.40

Paragon 28 announced the expiration of the HSR Act waiting period for its acquisition by Zimmer Biomet, indicating a step forward in the acquisition process.

Portfolio Pulse from

March 11, 2025 | 8:15 pm

Paragon Technologies' Nominating and Corporate Governance Committee, composed of three new independent directors, has issued a response to an open letter from Sham Gad, a director and former CEO of Paragon. The letter was released on February 11, 2025.

Portfolio Pulse from

February 18, 2025 | 2:45 pm

Sham Gad, a major shareholder of Paragon Technologies, has issued an open letter to stockholders, criticizing the company's board under Sam Weiser for fostering an anti-stockholder culture and using entrenchment tactics. Gad is also involved in a lawsuit challenging these actions.

Portfolio Pulse from

February 11, 2025 | 2:30 pm

Paragon Technologies updates on the independent investigation into former CEO Hesham M. Gad, highlighting its commitment to compliance and shareholder value.

Portfolio Pulse from

February 04, 2025 | 2:15 pm

Rowley Law PLLC is investigating potential securities law violations by Paragon 28, Inc. and its board regarding the proposed acquisition by Zimmer Biomet Holdings. Shareholders will receive $13.00 plus a contingent value right up to $1.00 per share.

Portfolio Pulse from

January 31, 2025 | 9:45 pm

Monteverde & Associates PC is investigating the merger of Paragon 28, Inc. with Zimmer Biomet Holdings, Inc. Zimmer Biomet will acquire all outstanding shares of Paragon 28 for $13.00 per share.

Portfolio Pulse from

January 29, 2025 | 7:15 pm

Zimmer Biomet announced its acquisition of Paragon 28 for approximately $1.1 billion.

Portfolio Pulse from

January 28, 2025 | 11:30 pm

Zimmer Biomet has announced a definitive agreement to acquire Paragon 28, expanding into the $5 billion foot and ankle segment. This acquisition is expected to enhance Zimmer Biomet's financial profile, being immediately accretive to revenue growth and accretive to adjusted EPS within 24 months of the deal's closure.

Portfolio Pulse from

January 28, 2025 | 11:15 pm

Paragon Technologies, Inc. has appointed three new independent directors, David Lontini, Howard Brownstein, and Tim Eriksen, to its Board of Directors. This change follows the retirement of long-serving board member Jack Jacobs.

Portfolio Pulse from

December 20, 2024 | 2:15 pm

Levi & Korsinsky has announced a class action lawsuit against Paragon 28, Inc. (NYSE:FNA) with a lead plaintiff deadline of November 29, 2024. Investors who suffered losses are encouraged to seek potential recovery under federal securities laws.

Portfolio Pulse from

November 29, 2024 | 10:15 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.